These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Synthesis and pharmacological investigation of novel 1-substituted-4-(4-substituted phenyl)-4H-[1,2,4]triazolo[4,3-a]quinazolin-5-ones as a new class of H1-antihistamine agents. Alagarsamy V; Giridhar R; Yadav MR J Pharm Pharmacol; 2006 Sep; 58(9):1249-55. PubMed ID: 16945184 [TBL] [Abstract][Full Text] [Related]
45. Synthesis of 4-butyl-1-substituted-4H-[1,2,4]triazolo[4,3-a]quinazolin-5-ones as new class of H(1)-antihistaminic agents. Alagarsamy V; Shankar D; Murugesan S Biomed Pharmacother; 2008 Mar; 62(3):173-8. PubMed ID: 17936567 [TBL] [Abstract][Full Text] [Related]
46. 4-Substituted semicarbazones of mono- and dichlorobenzaldehydes as antihypertensive agents. Warren JD; Woodward DL; Hargreaves RT J Med Chem; 1977 Nov; 20(11):1520-1. PubMed ID: 915918 [TBL] [Abstract][Full Text] [Related]
47. Synthesis and pharmacological investigation of some novel 2-methyl-3-(substituted methylamino)-(3H)-quinazolin-4-ones as histamine H1-receptor blockers. Alagarsamy V Pharmazie; 2004 Oct; 59(10):753-5. PubMed ID: 15544052 [TBL] [Abstract][Full Text] [Related]
48. Synthesis and pharmacological investigation of novel 4-(3-ethylphenyl)-1-substituted-4H-[1,2,4]triazolo[4,3-a] quinazolin-5-ones as a new class of H1-antihistaminic agents. Alagarsamy V; Kavitha K; Rupeshkumar M; Solomon VR; Kumar J; Kumar DS; Sharma HK Acta Pharm; 2009 Mar; 59(1):97-106. PubMed ID: 19304562 [TBL] [Abstract][Full Text] [Related]
49. The clinical evaluation of prazosin, a new antihypertensive agent. Pitts NE Postgrad Med; 1975 Nov; Spec No():117-27. PubMed ID: 1105484 [TBL] [Abstract][Full Text] [Related]
50. Synthesis, analgesic, anti-inflammatory and antibacterial activities of some novel 2-methylthio-3-substituted quinazolin-4-(3H)-ones. Alagarsamy V; Rajesh R; Ramaseshu M; Vijaykumar S; Ramseshu KV; Duraianandakumar T Biol Pharm Bull; 2004 May; 27(5):652-6. PubMed ID: 15133239 [TBL] [Abstract][Full Text] [Related]
51. Synthesis and pharmacological investigation of novel 4-(2-methylphenyl)-1-substituted-4H-[1,2,4]triazolo[4,3-a]quinazolin-5-ones as new class of H(1)-antihistaminic agents. Alagarsamy V; Rupeshkumar M; Kavitha K; Meena S; Shankar D; Siddiqui AA; Rajesh R Eur J Med Chem; 2008 Nov; 43(11):2331-7. PubMed ID: 18031870 [TBL] [Abstract][Full Text] [Related]
52. Double blind cross-over study comparing prazosin and methyldopa in the treatment of mild hypertension. Verhiest W; Croonenberghs J; Devos P; Fagard R; Amery A Acta Cardiol; 1974; 29(3):217-33. PubMed ID: 4601854 [No Abstract] [Full Text] [Related]
53. Design, synthesis and potential 6 Hz psychomotor seizure test activity of some novel 2-(substituted)-3-{[substituted]amino}quinazolin-4(3H)-one. Kumar P; Shrivastava B; Pandeya SN; Stables JP Eur J Med Chem; 2011 Apr; 46(4):1006-18. PubMed ID: 21306800 [TBL] [Abstract][Full Text] [Related]
54. [Synthesis and biological activity of substituted benzyl/naphthylmethylisoquinolines and related quaternary ammonium derivatives]. Xu GY; Peng SX; Hua WY Yao Xue Xue Bao; 1994; 29(2):95-106. PubMed ID: 8042518 [TBL] [Abstract][Full Text] [Related]
55. Effect of a novel antihypertensive agent, OR H3088, in the conscious goat. Eriksson L; Karppanen H; Honkanen E; Kokkonen UM Acta Pharmacol Toxicol (Copenh); 1984 Feb; 54(2):158-60. PubMed ID: 6711324 [No Abstract] [Full Text] [Related]